Markets:

Overview

News

Currencies

International

Treasuries

Adaptive Biotechnologies Corporation - Common Stock (NQ:ADPT)

17.09 +0.98 (+6.05%)

Streaming Delayed Price Updated: 12:12 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Adaptive Biotechnologies Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

ADAPTIVE BIOTECHNOLOGIES (NASDAQ:ADPT) – A Strong Growth Candidate Meeting Minervini’s Criteria ↗

May 13, 2025

ADAPTIVE BIOTECHNOLOGIES (ADPT) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a candidate for growth investors. The stock scores a perfect 10 on technical...

Via Chartmill

5 Analysts Assess Adaptive Biotechnologies: What You Need To Know ↗

May 05, 2025

Via Benzinga

Nasdaq Surges Over 300 Points; Apple Shares Fall After Q2 Results ↗

May 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 02, 2025

Via Benzinga

Trupanion Posts Better-Than-Expected Results, Joins Duolingo, DexCom, Exact Sciences And Other Big Stocks Moving Higher On Friday ↗

May 02, 2025

Via Benzinga

Earnings Scheduled For May 1, 2025 ↗

May 01, 2025

Via Benzinga

Adaptive Biotechnologies Reports First Quarter 2025 Financial Results

May 01, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs ↗

April 23, 2025

On Wednesday, April 23, 2025, Cathie Wood of Ark Invest purchased more stock of AMD and Nvidia amid looming US chip curbs against China.

Via Benzinga

Why Calix Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗

April 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 16, 2025

Via Benzinga

Adaptive Biotechnologies to Report First Quarter 2025 Financial Results on May 1, 2025

April 10, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Surveillance in Mantle Cell Lymphoma

April 08, 2025

clonoSEQ is now covered to monitor for recurrence in MCL patients who are in treatment-free remission

From Adaptive Biotechnologies

Via GlobeNewswire

Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 04, 2025

Via Benzinga

Why Sangamo Therapeutics Shares Are Trading Higher By Around 40%; Here Are 20 Stocks Moving Premarket ↗

April 04, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

April 02, 2025

Via Benzinga

Analyst Expectations For Adaptive Biotechnologies's Future ↗

March 21, 2025

Via Benzinga

Scholastic Posts Strong Earnings, Joins Ouster, Torrid Holdings, Adaptive Biotechnologies And Other Big Stocks Moving Higher On Friday ↗

March 21, 2025

Via Benzinga

Adaptive Biotechnologies Launches Assay Enhancements to Increase clonoSEQ® Sensitivity for Clinical MRD Detection in Diffuse Large B-Cell Lymphoma

March 11, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled ↗

March 10, 2025

Small caps took another step down this past week as geopolitical events dampened sentiment.

Via Talk Markets

Topics ETFs Stocks / Equities

Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive Biotechnologies ↗

February 22, 2025

Via Benzinga

Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results

February 11, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

February 05, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 11, 2025

January 22, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Earnings Scheduled For February 11, 2025 ↗

February 11, 2025

Via Benzinga

NeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term Guidance ↗

January 15, 2025

The company expects sales to grow 12% to 13% annually in the long term.

Via Investor's Business Daily

Adaptive Biotechnologies and NeoGenomics Partner to Expand Access to Personalized Disease Monitoring for Blood Cancer Patients

January 14, 2025

Pairing Adaptive Biotechnologies’ clonoSEQ MRD results with NeoGenomics’ COMPASS and CHART assessment services empowers clinicians and patients with meaningful insights across the treatment continuum

From Adaptive Biotechnologies

Via GlobeNewswire

Cathie Wood's Ark Invest Trims Palantir Again As Peter Thiel Co-Founded Firm's Stock Tumbles Nearly 15% In 2025 ↗

January 14, 2025

Cathie Wood-led Ark Invest sold 140,518 shares of Palantir and bought shares of Tempus AI Inc. The total value of the trades is about $9.1 million.

Via Benzinga

Topics Artificial Intelligence

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics Which Laid Off Over A Quarter Of Its Workforce ↗

January 11, 2025

Ark Invest, led by Cathie Wood, made significant trades in 5 companies on Friday: RXRX, ILMN, NTLA, NET, and ADPT.

Via Benzinga

Topics Workforce

Adaptive Biotechnologies Announces Clinical Lab Fee Schedule Rate of $2,007 for clonoSEQ® Test for Minimal Residual Disease Assessment is Effective as of January 1st, 2025

January 07, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks ↗

January 06, 2025

The healthcare sector is lagging over the past year and recent quarter with the XLV flat for 2024 and down over 4% for the recent quarter.

Via Talk Markets

Topics ETFs Stocks / Equities

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.